Anticoagulation and Bleeding Prevention
Research activity includes management of clinically relevant bleeding events in patients receiving direct oral anticoagulants and vitamin K antagonists, with a focus on bleeding control in the setting of tooth extraction.
- Tranexamic Acid for oral bleeding prevention
- Postoperative oral hemorrhage
- Orofacial hematomas
The therapeutic interest centers on reducing bleeding complications in dental procedures among anticoagulated patients.
Dental and Oral Surgery
Clinical research also addresses oral health and procedural hemostasis in patients undergoing single or multiple tooth extractions, where bleeding risk is a key concern.
- Oral surgery
- Extractions in anticoagulated patients
- Hemostatic support in dentistry
This area reflects interest in improving safety around minor surgical procedures performed in patients with elevated bleeding risk.
Cardiovascular Pharmacology
Another area of activity involves dofetilide, a cardiac antiarrhythmic agent, with attention to its pharmacokinetic and safety profile in healthy subjects.
- Antiarrhythmic therapy
- Cardiac rhythm management
- Systemic exposure assessment
The portfolio includes evaluation of formulations relevant to cardiovascular medicine and arrhythmia treatment.
Drug Formulation and Bioavailability
Hyloris Developments is also involved in comparative research on intravenous and oral formulations, with emphasis on bioavailability and tolerability in healthy volunteers.
- Intravenous-to-oral comparison
- Pharmacokinetic profiling
- Formulation assessment
This work supports development in specialty pharmaceuticals where route of administration and exposure characteristics are central.
